Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2015
Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancerStephen J Murphy, Robert J Karnes, Farhad Kosari, et al.Molecular Cell|September 8, 2015
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome DegradationJian An, Shancheng Ren, Stephen J Murphy, et al.Human Pathology|April 14, 2024
Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation studyKaitlyn J Nielson, Ross Rowsey, Surendra Dasari, et al.Cancer Genetics|February 7, 2018
SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)Sarah H Johnson, James B Smadbeck, Stephanie A Smoley, et al.The Journal of Molecular Diagnostics : JMD|September 17, 2022
Single-Nucleotide Polymorphism Array for Histologically Ambiguous Melanocytic TumorsKatherine B Geiersbach, Troy J Gliem, Sarah M Jenkins, et al.Mayo Clinic Proceedings|January 7, 2019
Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low-Risk From Intermediate- and High-Risk Prostate CancerGeorge Vasmatzis, Farhad Kosari, Stephen J Murphy, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2019
Using Genomics to Differentiate Multiple Primaries From Metastatic Lung CancerStephen J Murphy, Faye R Harris, Farhad Kosari, et al.Human Pathology|April 2, 2021
Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencingC Eric Freitag, William R Sukov, Alan H Bryce, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trialEdith A Perez, Robert B Jenkins, Amylou C Dueck, et al.Human Pathology|May 17, 2025
Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistryRumeal D Whaley, Daniel R Sill, Burak Tekin, et al.Pageof 15